Document:

Exhibit 10.4

MedPro

                                 PROMISSORY NOTE
                                     Between
                          MEDPRO SAFETY PRODUCTS, INC.
                                       AND
                                  CRM COMPANIES

      $2,000,000.00                                         September 1, 2006
                                                            Lexington, Kentucky

WHEREAS, MedPro Safety Products,  Inc. (the "Company"),  a Delaware corporation,
desires to restructure current debt and associated financial liabilities, and,

WHEREAS, CRM Companies,  Inc. at 201 West Short Street, Suite 800, Lexington, KY
("CRM Companies"), has agreed to convert portions of its loans to the Company to
capital  stock  and  structure  a note for the  remaining  amounts  due from the
Company; be it

RESOLVED,  that the  Company  enter  into this  Promissory  Note must  repay CRM
Companies  the  amount of  $2,000,000  ("Principal"),  and that said sum must be
repaid  on the date that the  Company  completes  an  equity  or debt  financing
resulting in gross proceeds to the Company of at least $6,000,000 (the "Maturity
Date");

ALSO  RESOLVED,  that in the event that the Company has not repaid the Principal
on or prior to  December  31,  2006,  the Company  will accrue  interest on this
Promissory  Note in the amount of 6.0% simple  interest  until the Principal has
been paid in full.

FINALLY  RESOLVED,  that if the  Principal  and  Interest  are not paid  back by
December  31,  2007  then a  penalty  of an  additional  interest  of 10% of the
Principal ("Penalty  Interest") will be granted on December 31, 2007, and for 5%
of the  combined  principal  and  interest  outstanding  every  sixty  (60) days
thereafter  for so long as the  note  Principal  and any  accrued  Interest  and
Penalty Interest are not paid back in full.

THE TERMINATION of this agreement shall be December 31, 2008, and the note shall
be callable.

THIS NOTE is in compliance  with the MedPro Safety  Products  Boards Approval of
August 24, 2006.

Agreed to this 1st day of September, 2006 by

      /s/ Walter W. Weller
--------------------------------------------
Walter W. Weller
President, MedPro, Inc.Exhibit 10.5

                                   SC CAPITAL
                                  PARTNERS, LLC

                                1992 N. Kolb Road
                                Tucson, AZ 85715
                                  520-290-5052

February 24, 2008

MedPro, Inc.
Attn: Craig Turner, Chief Executive Officer
817 Winchester Road, Suite 200
Lexington, KY 40505
Re: Financial Advisory Agreement

Dear Craig,

This letter will confirm the  understanding and agreement  ("Financial  Advisory
Agreement"  or  "Agreement")  between  SC  Capital  Partners,  LLC,  ("SCCP")  a
California  limited  liability  company  and  MedPro,   Inc.  ("MedPro"  or  the
"Company") a Nevada Corporation. Each hereinafter is referred to individually as
a "Party" and both are referred to  collectively  as the  "Parties." The Company
hereby engages SCCP to act as a non-exclusive  financial  advisor to the Company
and SCCP agrees to provide financial advisory services ("Services") as requested
by the Company from time to time during the term of the Engagement.

1.    Scope of Services.  The  Services,  either  collectively  or  individually
      ("Services"), to be provided by SCCP will include:

      (a.)  Advisory  Services.  SCCP will  provide  advice  and  assistance  in
            connection  with the  following:

            (i)   Representation  in the Equity  Financing.  SCCP will work with
                  the  Company  as to  the  timing,  feasibility,  pricing,  and
                  structure of the financing of the company.

            (ii)  Strategic planning.  SCCP will collaborate with the Company to
                  create a strategic plan that shall include:

                  o     Updated March 20, 2007 Confidential Company Memorandum.

                  o     A review of alternative business strategies.

                  o     Assistance with the execution of the selected  strategic
                        direction of the Company.

                                       1
<PAGE>

            (iii) Support the Company's shareholder liquidity building  efforts.
                  Assist Vision with programs to improve stock liquidity such as
                  coordination of research reports,  investor conferences,  road
                  shows, investor relations, and other activities.

      (b.)  Finder  Services.  SCCP  will  assist  with  future  equity  or debt
            financings  including.  but not limited to, the warrant  conversions
            associated  with  the  Convertible  Preferred  Transaction  or other
            financing transactions undertaken by the Company.

      (c.)  Merger and Acquisition Services.  SCCP will provide the Company with
            merger  and  acquisition  advice  to  include:  (i)  assist  in  the
            identification of businesses, assets or technologies; (ii) assist in
            financial modeling:  (iii) assist with the form and structure of the
            Transaction;  (iv) conduct  discussions  and  negotiations;  and (v)
            provide  other  related  advice and  assistance  as the  Company may
            reasonably request in connection with a Transaction.

      (d.)  Strategic  Alliances  Services.  SCCP shall provide the Company with
            potential  strategic  alliances.  These  services may  include:  (i)
            assist in the identification of businesses,  assets or technologies;
            (ii) assist in the  evaluation of third  parties;  (iii) assist with
            structure of the Strategic  Alliance;  (iv) conduct  discussions and
            negotiations  with a  Strategic  Alliance;  and  (v)  provide  other
            related advice and assistance to the Company.

2. Term.  SCCP's  initial  engagement  herein shall commence upon signing and is
expected  to be  completed  no  later  than six (6)  months  from  signing  date
("Minimum Term"). It shall continue thereafter on a month-to-month  basis unless
terminated in writing with 30 days notice by SCCP or the Company.

3.  Termination.  Subject to clause 2, either party may terminate this Agreement
for any reason upon giving thirty (30) days prior  written  notice to the other.
It is understood that upon  termination,  this Engagement  shall have no further
force or effect,  except that any termination of SCCP's engagement hereunder for
any reason shall not affect the Company's  obligation to pay SCCP fees for which
a definitive  agreement  specifically  identified by the Advisor has been signed
within 24 months after such dates  specified  and to  reimburse  expenses as set
forth herein and therein.

4. Compensation. The Company agrees to pay SCCP as compensation for its services
under this Engagement the following fees:

      (a.)  Advisory Fees:

            i.    A  Consulting  fee of $15,000  per month for the length of the
                  term.  The first  payment of $15,000 is due upon  signing  the
                  Agreement and is, thereafter, payable every 30 days.

            ii.   Equity  Financing.  The  Company  and  SCCP  entered  into  an
                  agreement regarding future compensation  arrangements  related
                  to the exercise of Warrants  associated  with the  Convertible
                  Preferred  Stock  investment  by Vision  Opportunity  Fund and
                  other investors (the "Convertible Preferred

                                       2
<PAGE>

                  Transaction").  At the Closing of equity Financing Transaction
                  completed   by  other   investors   not  covered   under  that
                  Convertible  Preferred  Transaction,  the Company will provide
                  the following compensation.

                        (a.)     Fees.  Pay SCCP a consulting fee equal to 8% of
                                 the  principal  cash  amount  of all  Company's
                                 securities and institutional PIPE and secondary
                                 financings introduced by SCCP.

                        (b.)     Warrants.  The Company  will provide SCCP or to
                                 its designees, warrants to purchase a number of
                                 Shares  or Units  equal to 8% of the  number of
                                 Shares  or  Units   sold   under   the   equity
                                 financing.  Each warrant  shall be identical in
                                 all  respects to those  publicly  or  privately
                                 offered by the Company and  exercisable  on the
                                 same terms.

            iii.  Debt  Financing.  The Company shall pay SCCP a consulting  fee
                  equal to 3% on any gross  proceeds  received by the Company in
                  connection with a Debt  Financing.  In the case of a committed
                  Debt  facility the  placement  fee will be  calculated  on the
                  gross available amount committed to the Company.

      (b.)  Merger and Acquisition  Services Fees:
            In connection with any Merger and Acquisition Transaction during the
            term of this Agreement  other than  "Unilife,"  SCCP shall be paid a
            Merger and  Acquisition  Transaction  fee equal to 2.5% on the first
            $20 million and 2.0% for any amount over $20 million  based upon the
            total Transaction Consideration as defined below:

            For purpose of this Agreement, "Transaction Consideration" means the
            aggregate  value,  whether  in  cash,  securities,   assumption  (or
            purchase  subject  to) of debt or  liabilities  (including,  without
            limitation,  indebtedness for borrowed money, pension liabilities or
            guarantees)  or other  property,  obligations  or services,  paid or
            payable directly or indirectly (in escrow or otherwise) or otherwise
            assumed in connection with a Merger and Acquisition Transaction,  or
            the net present  value of the  estimated  benefits to the Company of
            any joint venture, licensing or marketing agreement.

      (c.)  Strategic Alliances.  A consulting fee equal to 8% of the equivalent
            value  of any  strategic  alliance  or  other  business  realignment
            resulting from the SCCP Financial Advisory  Engagement not otherwise
            considered in this agreement. The equivalent value shall be mutually
            defined and paid in cash or in the form of payment of the particular
            transaction.

5.   Expenses.   The  Company  agrees  to  reimburse  SCCP  for  all  reasonable
out-of-pocket  expenses,  up  to  and  including  $1,000  per  instance  without
pre-approval and over $1,000 preapproved in writing by the Company,  incurred by
SCCP in connection with performance of the services discussed herein,  including
but not  limited to  printing,  copying,  office  supplies,  and travel  related
expenses.

                                       3
<PAGE>

6. Company Representations.  The Company represents and warrants that it has all
requisite  corporate  power and authority to execute and perform this agreement;
that it  constitutes  a valid and binding  obligation  of the  Company;  and the
execution and  performance  of this  agreement will not violate any provision of
the Company's  charter or bylaws or any  agreement or other  instrument to which
the Company is a party or by which it is bound.

7. SCCP Representations.  SCCP represents and warrants that it is not registered
as a brokerdealer pursuant to the Exchange Act; and is not a member of the NASD,
and is not presently,  and does not intend upon,  making any offer of Securities
on behalf of Company.  SCCP shall only provide  financial  advisory services and
act as a Finder in all instances related to the provision of Services herein.

8.  Confidentiality.  Subject to the exclusions set forth below, all information
exchanged  between the Parties under this  Agreement or during the  negotiations
preceding  this Agreement is  confidential.  Neither party shall disclose to any
third party (other than assigns  specific to this  agreement)  the other Party's
confidential information;  unless required by law or needed by a Party to assert
claims or defend  against  claims made  against the Party.  Each Party shall use
reasonable efforts to minimize such disclosure, and shall use reasonable efforts
to  obtain   assurance  that  the  recipient  shall  treat  the  information  as
confidential.  In addition,  either Party may disclose any such information that
becomes  generally  available  to the  public,  provided it is not the result of
disclosure in violation of the Section. Upon termination of this Agreement.  the
receiving  Party shall return all  confidential  information  of the  disclosing
Party or destroy any  material and shall  confirm in writing  such  destruction.
Notwithstanding  the forgoing,  the Company may disclose this  Agreement and its
terms to any  potential  investor  in, or  Purchaser  of, the  Company and their
respective representatives.

9.  Indemnification.  The Company agrees to indemnify and hold harmless SCCP and
its officers, directors, agents, employees and legal representatives controlling
SCCP or any of its affiliates within the meaning of Section 15 of the Securities
Act of 1933, as amended,  or Section 20 of the Securities  Exchange Act of 1934,
as amended  and its  respective  successors,  assigns,  executors  and  personal
representatives   ("Indemnified   Person(s)").   The  Company   will  hold  each
Indemnified  Person  harmless  from  and  against  any and all  losses,  claims,
damages,  and  liabilities  caused by, related to or arising out of, directly or
indirectly,  the  engagement  referred to in the  Agreement,  whether  under any
statute,  under common law, or otherwise.  The Company will also  reimburse SCCP
and  any  other  Indemnified  Person  for  all  reasonable  expenses  (including
reasonable  fees  and  disbursements  of  legal  counsel),  in  connection  with
investigating  or defending  any such action.  However,  the Company will not be
liable  under  this  paragraph  to the  extent  that any  loss,  claim,  damage,
liability  or  expense  is  found  in final  judgment  by a court  of  competent
jurisdiction  from which no appeal can be or is taken to have  resulted from the
gross negligence, willful misconduct or bad faith of SCCP.

If for any reason the foregoing  indemnification  is unavailable or insufficient
to any Indemnified  Person, then the Company will contribute the pro-rata dollar
amount in such  proportion as is  appropriate  to reflect the relative  benefits
received,   the  relative  fault  assigned,  or  any  other  relevant  equitable
considerations by the Company and SCCP.  However, in no event will the aggregate
contribution by SCCP and other  Indemnified  Persons hereunder exceed the amount
of fees actually received by them pursuant to the Agreement.

                                       4
<PAGE>

If notice of any such action is received  by an  Indemnified  Person in respect,
the Indemnified  Person shall notify the Company in writing of the  commencement
thereof.  However,  the  omission to so notify the Company  will not relieve the
Company from any liability to such Indemnified  Person hereunder,  except to the
extent  that such  failure  will have  actually  prejudiced  the defense of such
action,  SCCP  will  have the  right to  retain  counsel  of its own  choice  to
represent SCCP and all other  Indemnified.  Such counsel will cooperate with the
Company and any counsel  designated by the Company will pay the reasonable  fees
and  expenses of such counsel  retained by SCCP.  The Company will not be liable
hereunder  for any  settlement  made by SCCP  or any  other  Indemnified  Person
without the Company's  prior  written  consent,  which will not be  unreasonably
withheld.

These indemnifications, contribution and expense reimbursement provisions are in
addition to, and not in lieu of, any other  obligation or  liability,  which the
Company might otherwise have to SCCP or any other  Indemnified  Person.  Neither
termination  nor  completion  of  the  engagement  of  SCCP  referred  to in the
Agreement  will  affect the  provisions  of this  agreement,  which will  remain
operative and in full force. This agreement may not be amended orally.

10.  Survivability.  This  Agreement  and  any  rights,  duties  or  obligations
hereunder may not be waived, amended, modified or assigned, in any way, in whole
or in part, including by operation of law, without the prior written consent of,
and shall inure to the benefit of and be binding  upon the  successors,  assigns
and  personal  representatives  of,  each of the  parties  hereto.  In case  any
provision of this Engagement  shall be invalid,  illegal or  unenforceable,  the
validity, legality and enforceability of the remaining provisions of this letter
agreement shall not in any way be affected or impaired thereby.

11. Miscellaneous.

      a)    Unless subject to a separate Selling  Agreement in their performance
            hereunder,  the Parties are acting as independent  contractors,  and
            nothing contained herein shall be construed to create a partnership,
            joint  venture or other  agency  relationship  between the  Parties.
            Neither Party shall make any  communication to any person indicating
            that such  Party has the  right to act on  behalf  of,  bind or make
            promises or representatives for the other Party for any reason.
      b)    This  Agreement  and any  attached  exhibits  set forth  the  entire
            understanding  and agreement of the Parties and supersedes all prior
            and  contemporaneous  agreements and  understandings,  both oral and
            written,   related  thereto.  This  Agreement  may  be  executed  by
            facsimile  and in one or more  counterparts,  each of which shall be
            deemed to be an original,  but all of which shall constitute one and
            the  same  instrument.  Only a  written  instrument  signed  by both
            Parties may modify this Agreement.
      c)    Any notice or communication required or contemplated hereunder shall
            be in writing  and shall be  delivered  by hand,  deposited  with an
            overnight courier, sent by confirmed email, sent by facsimile with a
            sheet demonstrating successful transmission, or mailed by registered
            or certified mail,  return receipt  requested,  postage prepaid,  in
            each case to the address or number listed  below.  Such notice shall
            be deemed  given as of the date it is  delivered,  mailed,  emailed,
            faxed or sent.

                                       5
<PAGE>

      d)    This Agreement shall be binding to SCCP, MedPro and their respective
            successors  and  assigns.  Neither  Party may assign this  Agreement
            without the prior written consent of the other Party,  which consent
            shall not be unreasonably withheld.
      e)    No delay or omission by either Party to exercise any right or power,
            under this  Agreement  shall  impair or be  construed as a waiver of
            such right or power.  All  waivers  must be in writing and signed by
            the Party  waiving  its  right(s).  A waiver by either  Party of any
            breach  or  covenant  shall not be  construed  to be a waiver of any
            other breach or covenant.
      f)    The laws of the State of  California  shall  govern this  Agreement,
            without application of the principles of conflicts of laws.
      g)    The parties  shall attempt in good faith to resolve any such dispute
            through  good  faith  negotiation.  Any  dispute  which has not been
            resolved by  negotiation  within a 30 day period shall be settled by
            binding arbitration in Orange County, California, in accordance with
            the then  current  rules of the  American  Arbitration  Association,
            before  one  (1)  independent  and  impartial  arbitrator,  mutually
            designated  by both parties.  If the parties  cannot agree upon such
            arbitrator,  then  the  American  Arbitration  Association  shall be
            empowered to designate such arbitrator. The arbitrator's award shall
            be final  and any  court  having  jurisdiction  thereof  may  render
            judgment  thereon.  The arbitrator  may,  subject to any limitations
            placed on remedies by the terms of this Agreement,  grant any relief
            authorized by law,  including but not limited to, equitable  relief,
            declaratory  relief, and damages including punitive damages.  In the
            event that any arbitration  proceeding or other action is instituted
            concerning or arising out of this  Agreement,  the prevailing  party
            shall recover all of such party's out-of-pocket costs and reasonable
            attorney's fees incurred in each and every such  proceeding.  If any
            judicial  proceeding is required to enforce an arbitration ruling or
            to obtain equitable or injunctive relief, the parties hereby consent
            to the exclusive jurisdiction and venue of Orange County, California
            or the U.S.  District Court for the Southern District of California,
            whichever is applicable, for any such proceeding.

I am pleased to accept  this  engagement  and look  forward to working  with the
Company.   Please  confirm  that  the  foregoing  is  in  accordance  with  your
understanding  by signing and  returning  to us the  enclosed  duplicate of this
letter, which shall thereupon constitute a binding agreement.

                                       6
<PAGE>

Very truly yours,

SC Capital Partners, LLC                                MedPro, Inc

By:  /s/ Scott E. Hutchinson   By: /s/ Warran Rustand   By: /s/ Craig Turner
   -------------------------      -------------------      -------------------
Scott E. Hutchinson            Warran Rustand           Craig Turner
Managing Partner               Managing Partner         Chief Executive Officer
SC Capital Partners            SC Capital Partners      MedPro, Inc.

Date:        3/6/08            Date:   3/11/08          Date:   3/6/08
     -----------------------        ----------------         -----------------

Address for notices:

SC Capital Partners LLC                     MedPro, Inc.
1992 N. Kolb Road                           817 Winchester Road, Suite 200
Tucson, AZ  85715                           Lexington, KY 40505

                                       7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]